- Home
- MRSN vs SNT Comparison
MRSN vs SNT Comparison
Compare MRSN & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- SNT
- Stock Information
- Founded
- MRSN 2001
- SNT 1965
- Country
- MRSN United States
- SNT Canada
- Employees
- MRSN N/A
- SNT N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- SNT Telecommunications Equipment
- Sector
- MRSN Health Care
- SNT Telecommunications
- Exchange
- MRSN Nasdaq
- SNT Nasdaq
- Market Cap
- MRSN 71.9M
- SNT 78.3M
- IPO Year
- MRSN 2017
- SNT 1993
- Fundamental
- Price
- MRSN $0.53
- SNT $3.93
- Analyst Decision
- MRSN Buy
- SNT
- Analyst Count
- MRSN 7
- SNT 0
- Target Price
- MRSN $6.00
- SNT N/A
- AVG Volume (30 Days)
- MRSN 5.4M
- SNT 49.6K
- Earning Date
- MRSN 03-07-2025
- SNT 11-12-2024
- Dividend Yield
- MRSN N/A
- SNT N/A
- EPS Growth
- MRSN N/A
- SNT N/A
- EPS
- MRSN N/A
- SNT 0.06
- Revenue
- MRSN $34,837,000.00
- SNT $34,455,000.00
- Revenue This Year
- MRSN N/A
- SNT N/A
- Revenue Next Year
- MRSN N/A
- SNT N/A
- P/E Ratio
- MRSN N/A
- SNT $67.50
- Revenue Growth
- MRSN N/A
- SNT 2.04
- 52 Week Low
- MRSN $0.49
- SNT $1.08
- 52 Week High
- MRSN $6.28
- SNT $3.97
- Technical
- Relative Strength Index (RSI)
- MRSN 32.86
- SNT 62.97
- Support Level
- MRSN $0.56
- SNT $3.40
- Resistance Level
- MRSN $0.82
- SNT $3.90
- Average True Range (ATR)
- MRSN 0.07
- SNT 0.23
- MACD
- MRSN 0.03
- SNT 0.02
- Stochastic Oscillator
- MRSN 8.39
- SNT 92.97
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.